Injection sarcosine peptide aglycone powdery injection and its making method

Abstract

A powder injection in the light or dark yellow powder is prepared proportionally from polypeptide, hpyoxanthine and the excipient chosen from mannitol, sorbitol and dextran. It features that its ratio between its components varies with the chosen excipient.

Description

Technical field: The invention relates to carnosine glycosides, in particular to a carnosine glycoside powder for injection and a preparation method thereof. Background technique: Carnosine glycosides are extracted from healthy rabbit muscle and heart muscle and contain mixtures of polypeptides, amino acids, nucleosides and nucleotides. Nucleotides and various amino acids (essential amino acids) are important substances involved in human life activities. For diseases of the cardiovascular system, it can improve blood circulation disorders, reduce vascular resistance, increase myocardial oxygen utilization, etc. It can promote the activity of the hematopoietic system, increase the number of white blood cells, increase the elasticity of blood vessels, and prevent vascular sclerosis. Clinically, it is mainly used for brain dysfunction, cerebral apoplexy, cerebral hypofunction caused by insufficient blood supply to the brain, and peripheral nerve diseases. Polypeptides, amino ...

AI Technical Summary

Problems solved by technology

The extraction process of the sarcosaminoglycan glycoside solution described in the patents whose application numbers are 03104642.8 and 200310104970.8 respectively has a poor extraction effect on hypoxanthine

Images